جست‌وجوی استاد و پژوهشگر

• Dendrimers
• Luminescence
• Green Chemistry
• +۶ مورد دیگر

Vasco Bonifácio is an Assistant Professor at the Department of Bioengineering, Instituto Superior Técnico (IST), Lisbon, Portugal. He is affiliated with the Institute of Bioengineering and Biociences (INEB) and the Scientific Area of Biomaterials, Nanotechnology, and Regenerative Medicine. His research focuses on dendrimers, luminescent materials, green chemistry, mechanochemistry, and cancer theranostics. He teaches Biomolecular Engineering, Biomaterials Technology, and Integrative Biotechnology Projects. Bonifácio leads funded projects in cancer therapy, regenerative medicine, and drug delivery, including collaborations with Merck and AMGEN. He supervises PhD students in cancer metabolism, nanotherapeutics, and exosome engineering, and MSc students in protein stabilization. His scientific contributions include pioneering work on polyurea dendrimers for targeted drug delivery, mechanochemical synthesis of biometallic complexes, and sustainable molecularly imprinted polymers. He has developed novel dry powder formulations for pulmonary delivery and engineered exosomes for amyloid-beta clearance. Awards include the Outstanding Teaching Award (IST Pedagogical Council) and the Advanced Materials Scientist Medal (IAAM). Bonifácio's lab integrates nanomedicine, materials science, and sustainable chemistry. Key projects include tackling ovarian cancer chemoresistance via BSO nanodelivery and developing smart nanocarriers for targeted therapies. He also innovates in accessible science education for visually impaired users through tools like NavMol software.

Sophia Tsokaمشاهده پروفایل

دانشیار

• Computational genome analysis
• Genome data mining
• Network analysis and reconstruction
• +۷ مورد دیگر

Sophia Tsoka is a Reader in Bioinformatics at King's College London specializing in computational genome analysis, network reconstruction, and machine learning applications in cancer immunology and microbiome research. She leads the 'Algorithms for Antibodies' project funded by the Royal Society and serves as Co-Investigator on multiple research projects including 'Understanding the significance of patient B cells and expressed antibodies in melanoma' supported by the British Skin Foundation. Dr. Tsoka's research focuses on computational genome analysis, genome data mining, network analysis and reconstruction, metabolic networks, protein interaction networks, and the evolution of genome properties and dynamics. Her work bridges bioinformatics, machine learning, and immunology, with particular emphasis on applying computational approaches to understand antibody mechanisms, tumor microenvironments, and microbiome dynamics. She has developed innovative algorithms for network analysis, classification, and multi-omics data integration that have advanced our understanding of complex biological systems. Her recent publications demonstrate a strong trajectory in applying computational methods to cancer immunology, with multiple high-impact papers in 2025 spanning IgE antibody therapeutics, tumor microenvironment analysis, and machine learning approaches for biomedical data. These works reveal a consistent focus on developing interpretable computational models that can translate complex biological data into clinically relevant insights. Best paper award (2022) Best Paper Award (2020) Dr. Tsoka supervises numerous research projects and has secured significant grant funding from prestigious organizations including the Royal Society and British Skin Foundation. Her collaborative work spans multiple disciplines, connecting computational scientists with immunologists and clinicians to advance cancer therapeutics. She has established herself as a key contributor to the field of computational immunology with over 4,800 citations to her work. Her laboratory focuses on developing and applying advanced computational methods for analyzing complex biological networks, with particular emphasis on cancer immunology applications. The team combines expertise in algorithm development, machine learning, and biological data analysis to address challenging problems in antibody engineering and tumor microenvironment characterization.

Folami Ideraabdullahمشاهده پروفایل

دانشیار

• Gene-environment interactions
• Epigenetic reprogramming
• Developmental Origins of Health and Disease (DOHaD)
• +۶ مورد دیگر

Dr. Folami Ideraabdullah is an Associate Professor with tenure in the Department of Genetics at the UNC School of Medicine and holds a joint appointment in the Department of Nutrition at the Gillings School of Global Public Health. She serves as Research Director for Healthy Development and Aging in the NIEHS-funded P-30 UNC Center for Environmental Health and Susceptibility and as Lead PI for the NHGRI-funded R25 training program, UNC EDGE Genomics. Dr. Ideraabdullah was elected to a three-year term as a director of the Genetic Society of America in 2021 and was named to the list of 100 Inspiring Black Scientists in America by Cell Press in 2020. Dr. Ideraabdullah earned her BS in Biology (Genetics Option) from Pennsylvania State University in 2001, followed by a PhD in Genetics and Molecular Biology from UNC Chapel Hill in 2007. She completed postdoctoral training in Biology at the University of Pennsylvania from 2007-2012 before joining UNC as an Assistant Professor. She was promoted to Associate Professor with tenure effective January 1, 2021. Her research focuses on understanding gene-environment interactions through the lens of epigenetic mechanisms during development. The Ideraabdullah lab investigates how genetic background influences epigenetic responses to environmental factors such as nutrition (vitamin D, folate) and toxicants (endocrine disruptors like vinclozolin, arsenic). A key aspect of her work examines DNA methylation patterns during critical windows of germ cell and early embryonic development, with particular attention to how maternal health status affects offspring outcomes across generations. Her lab utilizes mouse models and has expanded to human studies including the SOWETO 1000 project in South Africa examining maternal obesity and gestational diabetes. Analysis of Dr. Ideraabdullah's recent publications reveals a consistent focus on transgenerational epigenetic inheritance, particularly how environmental exposures during critical developmental periods lead to persistent changes in DNA methylation patterns that affect metabolic and reproductive health across multiple generations. Her work bridges basic science with population health, examining how genetic variation influences susceptibility to environmental perturbations. Recent publications increasingly incorporate human studies alongside mouse models, reflecting a translational approach to understanding developmental origins of health and disease. Dr. Ideraabdullah's scientific recognition includes: Election as Director for the Genetic Society of America (2021) Inclusion in Cell Press's list of 100 Inspiring Black Scientists in America (2020) As a mentor and educator, Dr. Ideraabdullah leads the UNC EDGE Genomics program designed to increase diversity in the genomics workforce through undergraduate training. Her research program is supported by multiple NIH grants including the NIEHS-funded P-30 UNC Center for Environmental Health and Susceptibility where she serves as Research Director for Healthy Development and Aging. Her work has significant implications for understanding how environmental factors interact with genetic background to influence disease risk across generations, particularly in diverse populations. The Ideraabdullah lab maintains active collaborations across multiple disciplines, including toxicology, nutrition, genetics, and public health, with particular emphasis on creating more effective mouse models that better represent human population diversity. Her research group combines molecular techniques with computational approaches to analyze epigenetic changes across the genome.

• Medical Genetics
• Hereditary Cancer Syndromes
• Neurogenetics
• +۵ مورد دیگر

Selma DEMİR is an Assistant Professor in the Department of Medical Genetics at Trakya University Faculty of Medicine, where she has served since July 2017. Her academic foundation includes a Doctoral Degree (2011), Master's Degree (2005), and Bachelor's Degree (2003). Her research focuses on medical genetics with emphasis on hereditary cancer syndromes, neurogenetics, chromosomal abnormalities, and rare genetic disorders. Key areas include molecular diagnostics of neurofibromatosis type 1, hereditary hemorrhagic telangiectasia, DOORS syndrome, and Turkish population-specific genetic variants. She employs advanced techniques including array CGH, targeted resequencing, and MLPA for genetic analysis. Analysis of her 15 most recent publications reveals strong focus on Turkish patient populations, novel pathogenic variant discovery, and genotype-phenotype correlations across diverse conditions including cancer syndromes, neurodevelopmental disorders, and dermatological conditions. Her work frequently addresses population-specific genetic architecture in Thrace region. En iyi sözlü sunum ödülü (2017, Ege University) Sözlü sunum üçüncülük ödülü (2016, Erciyes University) Tübitak Ulusal Bilim Teşvik Ödülü (2006) Her funded projects include TÜBAP-2015-161 on mitochondrial DNA mutations in migraine patients, completed research on copy number variations in azoospermic males (2014-2017), and ongoing studies of genetic predisposition in differentiated thyroid cancer patients in Trakya region. While no formal students are listed, her collaborative work includes extensive research teams across Turkish institutions focusing on clinical genetics applications.

Vignir G Helgasonمشاهده پروفایل

عضو هیئت علمی

• Leukaemia Stem Cells
• Autophagy
• Cancer Metabolism
• +۴ مورد دیگر

Professor Vignir G Helgason is a Reader in Cancer Research at the Institute of Cancer Sciences, University of Glasgow , and leads the Helgason Laboratory at the Wolfson Wohl Cancer Research Centre . His work is centered on translational leukemia research, particularly focusing on leukemia stem cells, autophagy, and cancer metabolism. Education & Training: B.Sc. in Biology, University of Iceland (2000) Ph.D. in Tumour Cell Death Laboratory, Cancer Research UK Beatson Institute, University of Glasgow (2007) Post-doctoral training, Paul O’Gorman Leukaemia Research Centre Research Focus: Dr. Helgason’s team employs a "bench to bedside" approach, targeting leukemia stem cells to overcome drug resistance. Key areas include: Chronic Myeloid Leukemia (CML) biology Autophagy in leukemia stem cell survival Cancer metabolism and mitochondrial targeting Leukemia niche interactions Scientific Awards: Kay Kendall Leukaemia Fund Research Fellowship John Goldman Fellowship for Future Science University of Glasgow Leadership Fellowship Grants & Funding: His research is supported by major grants from Leukaemia UK , Blood Cancer UK , Cancer Research UK , Medical Research Council (MRC) , and Wellcome Trust , among others. Laboratory & Team: He leads the Helgason Laboratory (Leukaemia and Autophagy Therapeutics) at the Tommy Burns Laboratory , fostering interdisciplinary collaborations and training the next generation of cancer researchers.

• Cancer Metabolism
• Mitochondrial Biology
• Leukemia Research
• +۳ مورد دیگر

Dr. David Sumpton serves as an Honorary Senior Lecturer within the School of Cancer Sciences at the University of Glasgow, affiliated with the CRUK Scotland Institute in Glasgow. His research bridges cancer biology, metabolism, and therapeutic development, with particular focus on mitochondrial function in malignancies. His research interests center on cancer metabolism , especially mitochondrial pathways driving tumor progression and metastasis. Key areas include nucleotide metabolism (uridine phosphorylase), folate cycle regulation in leukemia, lipid signaling in metastatic niches, and immunometabolism interactions. His work demonstrates how metabolic rewiring enables immune evasion, metastatic colonization, and therapeutic resistance across prostate cancer, leukemia, and solid tumors. Analysis of his 2023-2025 publications reveals strong emphasis on metabolic vulnerabilities for therapeutic targeting, including drug repurposing (lomerizine for CML), mitochondrial DNA mutations enhancing immunotherapy response, and nutrient transporter dependencies (SLC7A5). His team frequently employs multi-omics approaches to stratify cancer subtypes and identify biomarker-driven treatments. While no formal advising or grant information is publicly documented, his collaborative publications across Nature journals, Science Translational Medicine, and Cell Biology indicate extensive institutional partnerships. His lab appears focused on translating metabolic discoveries into preclinical therapeutic strategies, particularly for treatment-resistant cancers. Dr. Sumpton maintains active research in tumor microenvironment dynamics, with recent work on extracellular vesicle-mediated metastatic niche formation and senescence-induced multi-organ dysfunction. His team utilizes physiological cell culture models to improve metabolic fidelity in cancer research.

• Enzymology
• Natural Products Biosynthesis
• Antimicrobial Compound Synthesis
• +۵ مورد دیگر

Dr. Joel Loveridge serves as an Associate Professor in the Department of Chemistry within Swansea University's Faculty of Science and Engineering. Previously a Senior Lecturer since joining Swansea in 2016, he established himself as part of the university's new Chemistry Department initiative after transitioning from Cardiff University where he held a Lectureship in NMR Spectroscopy since 2012. His academic journey began with an MSci in Chemistry with Industrial Experience and PhD in Biological Chemistry from the University of Bristol. His research spans enzymology, natural products biosynthesis, and antimicrobial compound synthesis, with particular expertise in NMR spectroscopy and enzyme dynamics. Early career work focused on dihydrofolate reductase mechanisms and protein dynamics, evolving toward applied research in fungal volatile organic compounds for agricultural applications. His publication record reveals a strategic shift from fundamental enzymology toward biocontrol solutions, particularly investigating Metarhizium species as sources of biostimulants and pest control agents. His 15 most recent publications demonstrate increasing collaboration with agricultural scientists, reflecting expansion into microbial pest management. The research trajectory shows progression from pure biochemical studies to field applications, with recent work examining VOC-based molluscicides, wireworm repellents, and slug management systems. This evolution highlights his commitment to translating biochemical insights into practical agricultural solutions. Fellow of the Higher Education Academy Organizer of Royal Society of Chemistry South Wales West Local Section's Science and Energy demonstration series Coordinator of Swansea University's Spectroscopy in a Suitcase program As an active supervisor, he currently mentors multiple PhD candidates investigating Metarhizium applications, plant protection mechanisms, and semiochemical-based pest control strategies. His teaching portfolio includes advanced organic chemistry, biological and medicinal chemistry, and analytical chemistry modules, reflecting his commitment to developing innovative chemistry curricula that integrate subject knowledge with professional skills. His public engagement efforts include chemistry carnivals at science festivals and extensive outreach through the Royal Society of Chemistry.

Philip Giffardمشاهده پروفایل

استاد

• Microbial Genomics
• Bacterial Evolution
• Molecular Epidemiology
• +۶ مورد دیگر

Philip Giffard is a Professor in Medical Laboratory Science at Charles Darwin University's Faculty of Health, with primary affiliation at Menzies School of Health Research. His research focuses on microbial genomics, bacterial evolution, and molecular epidemiology of important pathogens including Staphylococcus aureus and Streptococcus pyogenes, particularly in Northern Australian and Indigenous communities. Dr. Giffard's research interests center on understanding the genomic basis of bacterial pathogen evolution, transmission dynamics, and antimicrobial resistance. His work employs advanced genomic techniques including whole genome sequencing and high-resolution melting analysis to investigate pathogen transmission in remote communities, with particular emphasis on skin and throat infections in Aboriginal populations. His research has significant implications for public health interventions and vaccine development. His recent publications demonstrate expertise in genomic epidemiology, with a focus on mobile genetic elements, horizontal gene transfer, and the evolution of antibiotic resistance. Dr. Giffard has developed bioinformatics tools like minSNPs for microbial genomic analysis and has made significant contributions to understanding the transmission of streptococcal and staphylococcal pathogens in Northern Australia. Dr. Giffard has received research funding including the CDU Rainmaker Leverage Grant for medical equipment access. His work has been widely disseminated through high-impact publications in journals including Nature Communications, The Lancet Microbe, and mSphere, with his research being picked up by numerous news outlets and cited in policy sources. As a Principal Investigator, Dr. Giffard has led significant research projects investigating bacterial pathogens in Northern Australia. His work has important implications for understanding pathogen transmission in remote communities and developing effective public health interventions for skin and throat infections prevalent in these settings.

Lori Burrowsمشاهده پروفایل

استاد

• Antimicrobial resistance
• Bacteriology
• Biochemistry
• +۶ مورد دیگر

Professor Lori Burrows is a distinguished microbiologist at McMaster University's Faculty of Health Sciences, Department of Biochemistry & Biomedical Sciences. She serves as the Associate Director (Partnerships and Outreach) of McMaster University's Michael G. DeGroote Institute for Infectious Diseases Research. As a Fellow of the American Academy of Microbiology, she is recognized as an international expert in bacterial pathogenesis, particularly in the study of type IV pili and their role in bacterial virulence. Dr. Burrows' primary research interests focus on the structure, function, and regulation of type IV pili (T4P), which are ubiquitous bacterial virulence factors used for adherence, DNA uptake, biofilm formation, and twitching motility. Her laboratory primarily uses the opportunistic pathogen Pseudomonas aeruginosa as a model system to investigate pilin repertoire (relevant to vaccine design), pilin glycosylation systems involved in bacteriophage defense, structure-function of the pilus assembly system, and the complex regulation underlying T4P function. Additionally, her group studies biofilm formation, particularly the stimulation of biofilm development by sub-inhibitory antibiotic concentrations and the exploitation of this stimulation phenotype to discover new antimicrobials for multidrug-resistant gram-negative bacteria. Dr. Burrows' research program is robustly funded by multiple prestigious sources including the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada, the Canadian Glycomics Network, the Ontario Research Fund, and industrial support. Her publication record is impressive, with over 120 peer-reviewed papers, reviews, and book chapters, and an h-index of 49. Her recent work demonstrates continued leadership in understanding bacterial pathogenesis mechanisms, antibiotic resistance, and novel approaches to antimicrobial development. Fellow of the American Academy of Microbiology Dr. Burrows serves on the Editorial Boards of the Journal of Bacteriology (ASM), the Journal of Biochemistry (ASBMB), and ACS Infectious Diseases, demonstrating her significant contributions to the scientific community. Her laboratory, the Burrows Lab, is affiliated with both the Michael G. DeGroote Institute for Infectious Disease Research and the David Braley Centre for Antibiotic Discovery at McMaster University, positioning her research at the forefront of infectious disease and antibiotic discovery.

Catherine Metayerمشاهده پروفایل

استاد مدعو

• Environmental epidemiology
• Genetic epidemiology
• Epigenetics
• +۷ مورد دیگر

Catherine Metayer, MD, PhD, is an Adjunct Professor at the University of California, Berkeley's School of Public Health. A physician-scientist with dual training in medicine and epidemiology, she previously served as a scientist at the National Cancer Institute and currently chairs the Childhood Cancer and Leukemia International Consortium (CLIC). Her research focuses on environmental, genetic, and epigenetic factors in childhood cancers through the integrative CIRCLE center. University of Bordeaux II - MD Tulane University School of Public Health - PhD in Epidemiology Research Interests: Integrating environmental exposure assessment with molecular epidemiology, Dr. Metayer investigates: Environmental carcinogens in childhood leukemia and testicular cancer Epigenetic modifications from prenatal exposures Exposome-wide association studies using untargeted metabolomics Immune development in utero as cancer initiation mechanism Disparities affecting Latinx communities Translational research through pediatric specialty units Key Projects: Led the California Childhood Leukemia Study, Guatemala CRECERE, and Mexico's MIGICLL initiatives. Collaborates across multiple UC campuses, Yale, Mount Sinai, and international CLIC partners.

• Reproductive Endocrinology
• Endometriosis
• Uterine Development
• +۷ مورد دیگر

Hugh S. Taylor, MD serves as the Anita O'Keeffe Young Professor and Chair of the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, while also holding the position of Chief of Obstetrics and Gynecology at Yale New Haven Hospital. His dual appointment as Professor in Molecular, Cellular, and Developmental Biology underscores his interdisciplinary expertise. Board-certified in Obstetrics/Gynecology and Reproductive Endocrinology Director, Yale Center for Reproductive Biology Recipient of 10+ NIH grants President of American Society for Reproductive Medicine (2020-2021) Research Focus : Dr. Taylor's work spans endometriosis pathogenesis, uterine development , epigenetics , and stem cell therapy for reproductive disorders. He has pioneered understanding of HOX gene regulation in reproductive tract development and environmental endocrine disruptors like BPA. Recent Publications highlight his leadership in clinical trials (e.g., PRIMROSE fibroid studies), miRNA-based diagnostics for endometriosis, and novel applications of autologous stem cell therapy for Asherman's syndrome. His 2025 work on CD34+ KLF4+ stem cells demonstrates their role in endometrial regeneration. Honors & Leadership : National Academy of Medicine member (2016) IVI Foundation's Best Clinical Research in Reproductive Medicine (2024) Society for Gynecologic Investigation Distinguished Scientist (2020) Clinical Expertise includes complex cases of endometriosis , recurrent pregnancy loss , and thin endometrium . He leads NIH-funded studies on endometrial receptivity and epigenetic mechanisms in reproductive disorders.

Clavia Ruth Wooton-Keeمشاهده پروفایل

استادیار

• Hepatic Metabolism
• Nuclear Receptors
• Wilson's Disease
• +۱۲ مورد دیگر

Clavia Ruth Wooton-Kee, Ph.D. , is an Assistant Professor at Baylor College of Medicine in the Department of Pediatrics, with secondary appointments in Nutrition and Molecular and Cellular Biology. She leads an independent research laboratory at the USDA/ARS Children’s Nutrition Research Center in Houston, Texas, where she investigates the role of nuclear receptors in hepatic metabolism and chronic liver diseases, particularly Wilson’s disease. Her lab uses the Atp7b-/- mouse model to study metabolic dysfunction and copper-induced redox stress. Education: BSc in Biology and Chemistry, Union College (1996) MS in Biochemistry, University of Louisville School of Medicine (1999) PhD in Toxicology, University of Kentucky College of Medicine (2008) Her research focuses on how excessive copper disrupts nuclear receptor signaling (FXR, HNF4α, LRH-1), leading to bile acid dysregulation, mitochondrial damage, and spontaneous liver nodules. She explores therapeutic strategies involving nuclear receptor ligands and investigates transcriptomic and proteomic signatures in chronic liver diseases. Analysis of her recent publications reveals a strong focus on nuclear receptor biology, bile acid metabolism, Wilson’s disease, and metabolic adaptations during lactation. Her work spans molecular mechanisms, animal models, and translational applications, with a growing emphasis on gene regulation and therapeutic targeting. Scientific Awards: Presidential Poster Award, AASLD: The Liver Meeting, 2023 Dr. Wooton-Kee has received continuous grant funding from NIH/NIDDK and USDA/CRIS, including an R01 grant on nuclear receptor dysfunction in Wilson’s disease and a K01 Career Development Award. She has mentored researchers and presented her findings internationally, including at the Wilson Disease Aarhus Symposium in 2024. She also serves as a Faculty Senator at Baylor College of Medicine. Her lab is part of the USDA/ARS Children’s Nutrition Research Center, which provides state-of-the-art facilities including advanced laboratories, metabolic kitchens, and research volunteer accommodations, enabling cutting-edge research in pediatric nutrition and liver disease.

Michael Inouyeمشاهده پروفایل

استاد

• Systems Genomics
• Cardiovascular Disease
• Population Health
• +۳ مورد دیگر

Professor Michael Inouye is a leading systems genomics and population health researcher at the University of Cambridge (Department of Public Health and Primary Care) and Baker Heart & Diabetes Institute (Melbourne). His work bridges statistical genetics, computational biology, and clinical translation, with a focus on cardiovascular/respiratory diseases and sustainable research practices. Director of Research (Research Professor) since 2021 Honorary Professorial Fellow at University of Melbourne since 2021 Co-leader of Cambridge Baker Systems Genomics Initiative since 2017 Research Interests include: Polygenic risk score development and clinical implementation Multi-omic integration (genomics, proteomics, microbiomics) Host-microbiome interactions in disease Sustainable computational methodologies Cardiometabolic disease prevention Scientific Contributions show leadership in: Developing the Polygenic Score Catalog infrastructure Creating environmentally sustainable algorithmic frameworks Elucidating microbiome contributions to chronic diseases Advancing multi-modal risk prediction models Integrating genetic and metabolic pathway analysis Recent Publications demonstrate expertise across: Polygenic score optimization for blood traits and diabetes Microbiome-disease interaction networks Computational sustainability in biomedical research Cardiovascular risk stratification Multi-omic data harmonization Genetic determinants of molecular phenotypes

• Gastroenterology
• Medical Education
• Molecular Nutrition
• +۳ مورد دیگر

Martin Veysey is a Professor of Rural Medicine at Flinders University and a Consultant Gastroenterologist at Royal Darwin Hospital. He has held academic appointments including Senior Lecturer at the University of Newcastle and MBBS Programme Director at Hull York Medical School. His research spans gastroenterology , medical education , and molecular nutrition . Education MBBS, University of London (1991) Doctor of Medicine (MD), University of London (2001) Graduate Certificate in Tertiary Teaching, University of Newcastle (2010) Master of Clinical Education, Flinders University (2015) MBA in Higher Education Management, UCL (2017) Research Contributions His work explores the gut microbiome , bowel transit time , and gastrointestinal disease links to colorectal cancer , diverticulosis , and hemorrhoids . Recent studies include the vitamin D-folate hypothesis in human evolution and gut-lung axis in viral infections. Scientific Awards Fellow of the Royal College of Physicians (FRCP), UK Fellow of the Royal Australasian College of Physicians (FRACP) Professional Roles Martin leads undergraduate/postgraduate education initiatives, chairs the RACP CPD Committee , and is an Associate Editor for BMC Medical Education . He collaborates with institutions in Australia and the UK.

Benjamin C Warfمشاهده پروفایل

استاد

• Neurosurgery
• Global Health
• Pediatric Neurology
• +۴ مورد دیگر

Benjamin C Warf, MD is the Cummings Foundation Professor at Harvard Medical School and a neurosurgeon specializing in global health and pediatric hydrocephalus. His work focuses on improving surgical outcomes for children with hydrocephalus and spina bifida in low-resource settings, particularly sub-Saharan Africa. Dr. Warf pioneered the ETV/CPC surgical technique as an alternative to shunts, demonstrating comparable neurodevelopmental outcomes while reducing costs. He has extensively studied the epidemiology, pathogenesis, and socioeconomic impacts of hydrocephalus, including its correlation with infectious diseases like Paenibacillus infections and environmental factors such as arsenic exposure. His research has informed global health policy, including testimony before the U.S. House of Representatives that led to legislative proposals like the Global Brain Health Act. Dr. Warf collaborates with institutions worldwide through initiatives like the Paul Farmer Collaborative, emphasizing capacity-building in neurosurgical training and resource-limited healthcare systems. His work integrates clinical innovation with public health strategies to address disparities in pediatric neurosurgical care. Key contributions include randomized trials evaluating ETV/CPC efficacy, cost-benefit analyses of surgical interventions, and molecular studies linking environmental toxins to neural tube defects. He advocates for sustainable healthcare solutions through training programs, telemedicine mentorship, and partnerships with governments and NGOs.